| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | Chief Commercial Officer | Common Stock | 2,403 | $40,610 | $16.90 | 12 Dec 2025 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Commercial Officer | Restricted Stock Units | 149,734 | 12 Jan 2026 | Direct | ||
| Eton Pharmaceuticals, Inc. | Chief Commercial Officer | Employee Stock Option (Right to Buy) | 123,878 | 12 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | 12 Jan 2026 | 2 | $0 | 4 | Chief Commercial Officer | 14 Jan 2026, 18:05 |
| ETON | Eton Pharmaceuticals, Inc. | 11 Dec 2025 | 1 | -$1,436 | 4 | Chief Commercial Officer | 12 Dec 2025, 16:57 |
| ETON | Eton Pharmaceuticals, Inc. | 02 Dec 2024 | 0 | $0 | 3 | Chief Commercial Officer | 09 Dec 2024, 17:11 |